facebook

About Swiss Medica XXI

We started in 2011 in Lugano, Switzerland, when a group of medical specialists created a project to apply their knowledge in the field of regenerative medicine. They determined to realize the use of cell products in the treatment of various diseases, primarily those associated with the damage of tissues.

What Is Our Capability?

Swiss Medica specializes in the most cutting-edge stem cell therapies. We use more than 10 cell products, among them multipotent mesenchymal stromal cells (MMSCs), the stromal vascular fraction (SVF), fibroblasts, hematopoietic stromal cells, regulatory T-cells, dendritic cell vaccines, and mononuclear cells (MNC).

In our laboratories, we can cultivate and cryopreserve the patient’s own cells as well as donor cells, including placental cells. We also use all types of cell product administration (intravenous, intramuscular, local injections, etc.) to increase the likelihood of getting the intended result.

The Diseases We Treat

Since 2011 we have worked to develop experience in the application of cell products for the treatment of a large number of diseases. We see good efficacy of treatment in the following diseases:

  • trophic ulcers
  • diabetes type 2
  • diabetic foot
  • multiple sclerosis
  • arthritis and osteoarthritis
  • other rheumatic diseases
  • post-stroke condition
  • obesity
  • liver cirrhosis
  • chronic pancreatitis
  • erectile dysfunction
  • post-irradiation rectovaginal fistulas
  • Parkinson’s disease
  • dementia, and many other disorders.

We also use medical programs that help prevent and reverse the external and internal symptoms of aging.

Departments of Swiss Medica

The headquarter of Swiss Medica is in Goldach (St. Gallen, Switzerland). However, this location does not typically apply stem cell treatment due to cost and restrictive legislation in Switzerland. For this reason, patients are not treated here.

In Lugano, there is a research center where cells are studied and the development of innovative treatment methods is carried out. Also in Switzerland, the clinic’s specialists are trained to participate in international conferences to share and gain experience in stem cell treatment.

In Dornbirn, Austria, there is an outpatient clinic that specializes in short therapeutic programs primarily aimed at the treatment of joints, and skin, including anti-age programs. Here is also a cell research center. Currently, this clinic is under reconstruction.

Our main therapeutic base is located in Belgrade, Serbia. In this inpatient clinic, we have the medical resources to treat a wide range of diseases and disorders. Patients here undergo full-scale therapy consisting of cell product introduction and rehabilitation therapies, such as IMR therapy, shockwave, laser, ultraviolet blood irradiation, plasmapheresis, extracorporeal spark wave, etc. These methods help to improve regeneration and revascularization of damaged areas, allowing for the realization of better results in the treatment with cell products.

What Is Swiss Medica Today:

  • 2 clinics
  • 2 laboratories
  • Own cryobank for stem cells
  • 2 training centers
  • 14 types of cell products
  • 50+ methods of rehabilitation
  • A team of 250+ people
  • Own manufacture of medicines

Contact us

Contact us, and our doctors will recommend you an individual treatment program for your case and medical needs.

About Swiss Medica XXI
Dr. Aleksandra Fetyukhina, MD

Medical Advisor, Swiss Medica doctor